carvacrol has been researched along with Adenocarcinoma of Lung in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bahuguna, A; Bajpai, VK; Kang, SC; Khan, I; Kumar, P | 1 |
Bajpai, VK; Bhardwaj, M; Huh, YS; Kang, SC; Khan, I; Lee, H; Oh, MH; Shukla, S | 1 |
2 other study(ies) available for carvacrol and Adenocarcinoma of Lung
Article | Year |
---|---|
In vitro and in vivo antitumor potential of carvacrol nanoemulsion against human lung adenocarcinoma A549 cells via mitochondrial mediated apoptosis.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Line, Tumor; Cell Survival; Cymenes; Emulsions; Gene Expression Regulation; Humans; Lung Neoplasms; Membrane Potential, Mitochondrial; Mice; Mitochondria; Monoterpenes; Reactive Oxygen Species | 2018 |
Carvacrol encapsulated nanocarrier/ nanoemulsion abrogates angiogenesis by downregulating COX-2, VEGF and CD31 in vitro and in vivo in a lung adenocarcinoma model.
Topics: Adenocarcinoma of Lung; Animals; Antineoplastic Agents; Cell Proliferation; Cyclooxygenase 2; Cymenes; Down-Regulation; Drug Carriers; Drug Screening Assays, Antitumor; Emulsions; Humans; Lung Neoplasms; Mice; Nanoparticles; Neoplasms, Experimental; Neovascularization, Pathologic; Particle Size; Platelet Endothelial Cell Adhesion Molecule-1; Surface Properties; Tumor Cells, Cultured; Vascular Endothelial Growth Factors | 2019 |